JAK2 and cardiovascular disorder: JAK2 V617F mutation is the predominant mutation in MPNs and also the mutation most strongly associated with cardiovascular disease risk.11 It causes constitutive activation of JAK/STAT signaling which promotes expression of inflammatory cytokines, reactive oxygen species, production of oxidative low-density lipoproteins and formation of foam cells.